BioCardia Inc (BCDA)
2.26
+0.12
(+5.85%)
USD |
NASDAQ |
Nov 22, 16:00
2.27
+0.01
(+0.44%)
After-Hours: 20:00
BioCardia Cash from Investing (Quarterly): -0.002M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.002M |
| June 30, 2024 | -0.003M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.002M |
| March 31, 2023 | -0.01M |
| December 31, 2022 | -0.002M |
| September 30, 2022 | -0.014M |
| June 30, 2022 | -0.025M |
| March 31, 2022 | -0.029M |
| December 31, 2021 | -0.041M |
| September 30, 2021 | -0.02M |
| June 30, 2021 | -0.028M |
| March 31, 2021 | -0.027M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.023M |
| June 30, 2020 | -0.004M |
| March 31, 2020 | -0.005M |
| December 31, 2019 | -0.002M |
| September 30, 2019 | -0.02M |
| June 30, 2019 | -0.069M |
| March 31, 2019 | -0.055M |
| December 31, 2018 | -0.015M |
| September 30, 2018 | -0.005M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.041M |
| March 31, 2018 | -0.005M |
| December 31, 2017 | 1.77M |
| September 30, 2017 | -0.01M |
| June 30, 2017 | -1.832M |
| March 31, 2017 | -0.064M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.90M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.041M
Minimum
Dec 2021
--
Maximum
Dec 2020
-0.0119M
Average
-0.0045M
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -30.25M |
| The Cooper Companies Inc | -124.10M |
| Theriva Biologics Inc | 0.00 |
| Zevra Therapeutics Inc | -31.35M |
| Instil Bio Inc | 19.81M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.611M |
| Cash from Financing (Quarterly) | 6.122M |
| Free Cash Flow | -7.309M |
| Free Cash Flow Per Share (Quarterly) | -0.9241 |
| Free Cash Flow Yield | -164.1% |